The therapy, haploidentical bone marrow transplant with thiotepa and posttransplant cyclophosphamide, is as safe and more affordable than the recently FDA-approved myeloablative gene therapy and gene editing treatments.
Department of Medicine clinicians see patients in 19 counties across Middle Tennessee as well as the surrounding region. There were 86,096 outpatient visits for fiscal year 2024, an increase of more than 25,000 visits over fiscal year 2023.
Jane Freedman, MD, professor of Medicine and interim chair of the Department of Medicine, delivered the annual State of the Department address on June 20, highlighting those who form the department and celebrating major achievements in the past year.
Cathy Eng, MD (Hematology and Oncology), is corresponding author of a paper published last week in The Lancet that provides an overview on treatment advances, clinical trials, incidence trends and ongoing challenges related to colorectal cancer, the third most diagnosed cancer in the world.
Alvin Powers, MD (Diabetes, Endocrinology and Metabolism), last week received the American Diabetes Association's (ADA) 2024 Albert Renold Award at the ADA's 84th Scientific Session in Orlando.
The award recognizes an individual who has made outstanding contributions to the training and mentorship of diabetes research scientists.
Preoxygenation is the administration of supplemental oxygen prior to the start of a procedure to increase the content of oxygen in the lung and decrease the risk of hypoxemia
Annet Kirabo, DvM, MSc, PhD, Associate Professor of Medicine (Clinical Pharmacology), is among 13 highly accomplished and recently tenured Vanderbilt University faculty who have been selected for the 2024 cohort of Chancellor Faculty Fellows.
The Vanderbilt Diabetes Research and Training Center (DRTC) recently hosted its annual Diabetes Day, where they highlighted recent advancements in the field and recognized young investigators for their research efforts. One of 17 diabetes research centers in the United States, the Vanderbilt DRTC today is comprised of 140 faculty members from 15 departments and three colleges or schools at Vanderbilt and Meharry Medical College who conduct basic, clinical and translational research on the cause, prevention, treatment and complications of diabetes and obesity.
Roughly one in 10 people over age 70 will develop CHIP, an explosive, clonal growth of abnormal blood cells that increases risk of blood cancers and death from cardiovascular, lung and liver disease.
People whose white blood cell levels are near the edge of the “healthy” reference range will hit a clinical decision point that has consequences such as diagnostic procedures and altered treatments.
Researchers at Vanderbilt University Medical Center and the VA Tennessee Valley Healthcare System have demonstrated in a small clinical study that “turning up the heat” on fat may help people lose weight and reduce their risk of obesity-related cardiovascular and metabolic disease.
